Ziagen (Abacavir)
| Brand Name: |
Ziagen |
| Generic Name: |
Abacavir, ABC |
| Adult Single Dose: |
300 mg twice daily OR 600 mg once daily |
| Food & Liquid Restrictions: |
None |
| Drug Class: |
NRTI |
The Basics
- Abacavir (Ziagen) (November 15, 2012)
To read PDF, click here.
From AIDS InfoNet
- An Overview of Ziagen (Abacavir) (September 14, 2012)
From AIDSinfo
- Ziagen (March/April 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Patient Information About Ziagen (Abacavir) (PDF) (November 2011)
From ViiV Healthcare
- Ziagen (Abacavir) (September 28, 2008)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
- Abacavir (Ziagen) (July 15, 2008)
From AIDS Treatment Data Network
- Ziagen (Abacavir) (May 2005)
To read PDF, click here.
From The Center for AIDS
- Drug Interactions: Abacavir (August 2004)
From Project Inform
- HEPPigram: Management of the Abacavir Hypersensitivity Syndrome (AHS) (January 2002)
To read PDF, click here.
In HEPP News, from Brown Medical School
News
- Approval of Generic Abacavir Tablets, 300 mg (June 20, 2012)
From U.S. Food and Drug Administration
- FDA Finds No Heart Attack Risk With HIV Drug (March 2, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Ongoing Abacavir Safety Review Finds No Increased Risk of Heart Attack (March 1, 2011)
From U.S. Food and Drug Administration
- Why Is Ziagen Associated With Heart Attacks in Some People? New Study Offers Possible Explanation (September 30, 2009)
From aidsmap.com
- Ziagen 300 mg Scored Tablet Facilitates Pediatric Treatment of Infection With HIV (December 19, 2008)
From U.S. Food and Drug Administration
- GlaxoSmithKline Announces New Program to Provide Financial Assistance for Eligible HIV Patients in the U.S. (November 11, 2008)
If you live in the United States, use private health insurance and take Combivir (AZT/3TC), Epzicom (abacavir/3TC, Kivexa), Lexiva (fosamprenavir, Telzir) or another HIV drug made by GlaxoSmithKline, you may have a chance to save a nice chunk of change.
From GlaxoSmithKline
- Important Safety-Related Label Update for Ziagen (Abacavir Sulfate) (July 18, 2008)
From U.S. Food and Drug Administration
- Ziagen's Heart Attack Link: How Long Has Glaxo Known? (May 12, 2008)
In The Independent
- Guidelines Panel Responds to Abacavir Data (April 10, 2008)
From Project Inform
- Early Communication About an Ongoing Safety Review of Ziagen (Abacavir) and Videx (Didanosine) (March 27, 2008)
From U.S. Food and Drug Administration
VIEW ALL ARTICLES
|
|
Advertisement
|
Email
Glossary
